# China NMPA Drug Inspection - Yunnan Mingjing Hengli Pharmaceutical Co., Ltd. - Berberine Hydrochloride Tablets

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/yunnan-mingjing-hengli-pharmaceutical-co-ltd/d4e4d1dd-33b9-4566-93cf-5ed5bc4992ef/
Source feed: China

> China NMPA drug inspection for Yunnan Mingjing Hengli Pharmaceutical Co., Ltd. published October 29, 2021. Drug: Berberine Hydrochloride Tablets. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: The Yunnan Provincial Drug Administration issued the third issue of its 2021 Drug Quality Bulletin.
- Company Name: Yunnan Mingjing Hengli Pharmaceutical Co., Ltd.
- Publication Date: 2021-10-29
- Drug Name: Berberine Hydrochloride Tablets
- Inspection Finding: Compliant

Company: https://www.globalkeysolutions.net/companies/yunnan-mingjing-hengli-pharmaceutical-co-ltd/17168d0a-48d3-4701-84a1-0dba605981c8/